Table 2 Laboratory findings of all studied cases.
From: Evaluation of kidney dysfunction in childhood cancer survivors
Laboratory findings | Total studied cases (No. = 52) | |||
|---|---|---|---|---|
Mean | Median | SD | Range | |
Hb (gm/dl) | 12.8 | 12.8 | 1.4 | 10–16 |
WBCs (×103/mm3) | 6.3 | 5.8 | 2.6 | 4–13.7 |
Platelet ((×103/mm3) | 250.7 | 241 | 71.4 | 160–452 |
Na (mEq/L) | 135.3 | 135 | 1.5 | 134–139 |
K (mEq/L) | 4.1 | 4 | 0.31 | 3.7–5 |
Ca (mg/dl) | 9.2 | 9 | 0.54 | 8.5–10.6 |
Serum urea (mg/dl) | 22.5 | 23 | 4.1 | 12–28 |
Serum creatinine (mg/dl) | 0.79 | 0.80 | 0.12 | 0.6–1.1 |
eGFR (mL/min./1.73m2) | 104.5 | 100 | 17.8 | 75–135 (12 cases <90) |
Uprotein/Cr | 0.33 | 0.38 | 0.09 | 0.12–0.46 (25 cases >0.25) |
UACR (mg/g) | 45 | 25 | 17.3 | 10–75 (25 cases >30) |
UCa/Cr | 0.28 | 0.32 | 0.12 | 0.15–0.45 (25 cases >0.22) |
Uric acid in urine. Normal value (250–750 mg/24 h) | 340.8 | 320 | 140.5 | 160–700 |
Serum cystatin C (mg/L) | 122.6 | 112.5 | 57.4 | 40–300 |
UrNGAL (ng/ml) | 1989.9 | 1983.5 | 488.4 | 1061–3114 |
UrNGAL/Cr | 2598.6 | 2437.5 | 738.1 | 1178–3974 |
